Investigator’s Brochure Writing: 5 Tips to Streamline Your SOC
Streamline developing a summary of changes for an Investigator’s Brochure, a document that summarizes the…
Certara2025 年 2 月 19 日
How to Modernize Patient Narrative Writing
Lorem ipsum dolor sit amet consectetur. Donec diam risus volutpat tempor. Massa accumsan aliquam nibh…
Danielle Pillsbury2025 年 2 月 12 日
Certara’s Phoenix Platform – The world’s most trusted platform for PK/PD analysis and modeling
Today's drug candidates are more complex than ever. But with development decisions on the line,…
Certara2025 年 2 月 12 日
Population Pharmacokinetic and Pharmacodynamic Analysis of Navtemadlin in Patients with Relapsed and Refractory (R/R) Myelofibrosis (MF) and Other Myeloid or Solid Tumor Malignancies
This study conducted a population pharmacokinetic (PK) and pharmacodynamic (PD) analysis of navtemadlin, an MDM2…
Danielle Pillsbury2025 年 2 月 6 日
Best Practices for International Pharma Content Roll-Out
2025 年 1 月 31 日 Pharmaceutical market access, sales, and field teams rely on high-quality, effective content…
Certara2025 年 1 月 31 日
Transforming Perspectives: 25 Years of PBPK Modeling in Drug-Drug Interactions
Vice President and Head of Global PK/PD and Pharmacometrics at Eli Lilly and Company Dr.…
Danielle Pillsbury2025 年 1 月 29 日
